
Expa


We are strongly committed to innovation Our conviction is that a more scientific approach will be crucial to provide solutions that stand the test of time Tomorrow, our planet’s resources will diminish whereas our technological prowess will increase Some technological advances are particularly timely to address the challenges of our food system They can give life to transformational processes and approaches
We invest in early-stage companies, from Seed to Series C Strong intellectual property, scientifically rigorous, delivery-focused management teams, and the ability to apply solutions globally — especially to Asia — are some of the qualities we seek in our target portfolio companies
Seed, Series A and Series B investments with follow-ons to Series C total equity funding raised across portfolio companies relevant start-up companies in proprietary pipeline
The industrialisation of food has greatly improved the capacity and efficiency of our food system Yet, this reality is changing – for far too long, capital has been deployed at the expense of our planet; resources are exploited, natural habitats are destroyed and pollutants have been released irresponsibly into our environment In a resource-constrained world, the status quo simply cannot continue The same holds true for the effects of mass-produced foods on our health In our opinion, investing can only be truly impactful if the solutions we invest in enable industries to produce foods that are not only beneficial to your health but also affordable and with much fewer resources
'Impact' investing was never about compromising financial performance Rather, it is ensuring that capital is deployed with rigour to help reshape how companies approach their businesses Ensuring the sustainability of our finite resources and promoting healthier processes are afterall the only way to ensure that businesses can flourish indefinitely
At VisVires New Protein, 'impact' is a cornerstone of our investment approach To date, our investments address ten of the UN Sustainable Development Goals
We work closely with the management teams of our start-up companies to identify strategies for both value creation and value capture A lot has been said about creating value However, it doesn’t do much for the start-up company if most of the value created accrues to others in the chain We help the company to pivot its business model if necessary, to help it capture more of the value
In addition to business, our team has a strong scientific and technical expertise All of us have an extensive network of contacts among global food, beverage and feed companies (from brand owners to ingredients innovators and suppliers) that we can leverage to help secure partnerships for our start-up companies
Dr Sze Tan acts as an independent industry expert on our Investment Committee (IC) She is responsible for providing an objective assessment of each investment proposal
Dr Sze Tan is the Chief Technology Officer of CJ Cheiljedang (CJ Foods), the company's first non-Korean CTO Dr Tan has a penchant for breaking barriers, spending her last 23 years with Nestlé and was the first Singaporean to be appointed Managing Director of its R&D centre in Singapore
To further strengthen our investment thesis and maximise value creation for our start-up companies, we have assembled an Innovation Advisory Committee (IAC) The IAC comprises academia and industry professionals who are recognised leaders in the global food, nutrition, and agriculture domains
We are located in Singapore, in the heart of one of the fastest growing regions in the world It is a major R&D hub for agrifood companies With its receptiveness to new technologies and availability of talent, the city is an attractive location for start-up companies looking for a springboard to the larger Asian region
We love to hear about your venture! Tell us more about:
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about New Protein Capital.
Similar listings buyers compare against this one.

Expa

Applied Materials

Boston Scientific

Analog Devices

Kleiner Perkins Caufield & Byers

Insight Partners
Everything here links back to the same verified catalogue. Pick your next stop.